Last Updated: August 2, 2026

diethylpropion hydrochloride - Profile


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for diethylpropion hydrochloride and what is the scope of patent protection?

Diethylpropion hydrochloride is the generic ingredient in five branded drugs marketed by Lannett Co Inc, Sanofi Aventis Us, Ani Pharms, 3M, Avanthi Inc, Chartwell Rx, Epic Pharma Llc, Sandoz, Teva, Ucb Inc, Watson Labs, and Mpp Pharma, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

Summary for diethylpropion hydrochloride
US Patents:0
Tradenames:5
Applicants:12
NDAs:16

US Patents and Regulatory Information for diethylpropion hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Co Inc DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 091680-001 Oct 24, 2011 RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sanofi Aventis Us TENUATE diethylpropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 017669-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Ani Pharms TENUATE DOSPAN diethylpropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 012546-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
3m TEPANIL TEN-TAB diethylpropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 017956-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Avanthi Inc DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET;ORAL 201212-001 Dec 22, 2010 AA RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Chartwell Rx DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET;ORAL 088267-001 Aug 25, 1983 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Chartwell Rx DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET;ORAL 088268-001 Aug 25, 1983 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.